Oct 14 (Reuters) - Janssen Biotech Inc:
* Johnson & Johnson (N:JNJ) Innovation announces collaborations with Canadian Biotechs Novera Therapeutics, Inc. and Engene, Inc
* Janssen biotech inc - agreements seek new treatments for hematological
malignancies and inflammatory bowel disease
* Janssen biotech - agreement with novera is collaboration that includes
Ontario institute for cancer research together with university health network
* Janssen biotech - agreement will allow janssen to accelerate the development
of promising small molecule drug candidates for hematological cancers
* Janssen biotech - separate agreement with engene allows for development and
commercialization of new therapies for inflammatory bowel disease
* Janssen biotech - engene and janssen will jointly develop eg-12 through to
clinical proof of mechanism in patients with ibd
* Janssen biotech - upon exercise of option, janssen will take further clinical development and commercialization of eg-12 for all indications worldwide
* Source text for Eikon ID:nCNWpRhPwa
* Further company coverage JNJ.N